Alkem Laboratories Limited
NSE: ALKEM · Healthcare
₹5,368.00
+18.00 (+0.34%)
Last close · 30 Aug 2026, 2:50 am IST
- Open
- ₹5,378.00
- Day high
- ₹5,378.00
- Day low
- ₹5,297.00
- Volume
- 48.1 K
- Prev close
- ₹5,350.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 200Nifty 500Nifty HealthcareNifty Midcap 100Nifty Midcap 150Nifty Midcap 50Nifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 67,357 Cr
- Price
- 5,633.50
- P/E (TTM)
- 29.24
- P/E (Fwd)
- 24.90
- P/B
- 4.88
- EV/EBITDA
- 21.62
- EV/Revenue
- 4.42
- PEG
- —
- Div Yield
- 0.36%
- 52W High
- 5,933.50
- 52W Low
- 4,738.50
- Beta
- 0.27
Profitability & income
- Revenue (TTM)
- 14,712 Cr
- Net Income (TTM)
- 2,302 Cr
- EBITDA
- 3,005 Cr
- Gross Margin
- 65.38%
- Op. Margin
- 11.42%
- Net Margin
- 15.65%
- ROE
- 17.56%
- ROA
- 8.50%
- EPS (TTM)
- 192.67
- EPS (Fwd)
- 226.20
Financial health
- Total Debt
- 2,047 Cr
- Total Cash
- 4,993 Cr
- Debt/Equity
- 14.27
- Current Ratio
- 2.55
- Quick Ratio
- 1.67
- Book Value
- 1,155.47
- Free Cash Flow
- 1,374 Cr
- Op. Cash Flow
- 1,963 Cr
Growth
- Revenue Growth
- 14.60%
- Earnings Growth
- -22.70%
- Earnings QoQ
- -22.70%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3,603 Cr | 236 Cr | 582 Cr | 412 Cr | 2,355 Cr | — | 2,047 Cr | 13,820 Cr |
| 2025-12-31 | 3,737 Cr | 636 Cr | 918 Cr | 733 Cr | 2,464 Cr | — | — | — |
| 2025-09-30 | 4,001 Cr | 765 Cr | 1,024 Cr | 827 Cr | 2,600 Cr | — | 2,356 Cr | 13,346 Cr |
| 2025-06-30 | 3,371 Cr | 664 Cr | 888 Cr | 651 Cr | 2,200 Cr | — | — | — |
| 2025-03-31 | 3,144 Cr | 306 Cr | 537 Cr | 279 Cr | 1,864 Cr | — | 1,381 Cr | 11,985 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 14,712 Cr | 2,302 Cr | 3,414 Cr | 2,623 Cr | 9,620 Cr | 1,963 Cr | 2,047 Cr | 13,820 Cr |
| 2025-03-31 | 12,965 Cr | 2,165 Cr | 3,006 Cr | 2,155 Cr | 8,200 Cr | 1,913 Cr | 1,381 Cr | 11,985 Cr |
| 2024-03-31 | 12,439 Cr | 1,796 Cr | 2,418 Cr | 1,985 Cr | 7,407 Cr | 1,948 Cr | 1,418 Cr | 10,312 Cr |
| 2023-03-31 | 11,440 Cr | 984 Cr | 1,709 Cr | 1,334 Cr | 6,458 Cr | 1,683 Cr | 1,397 Cr | 9,045 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for ALKEM?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in